AXA S.A. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
AXA S.A. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$650,368
-44.7%
22,250
-50.0%
0.00%0.0%
Q3 2022$1,175,845
-47.6%
44,500
-11.9%
0.00%
-50.0%
Q2 2022$2,243,858
-29.2%
50,500
-21.1%
0.00%
-20.0%
Q1 2022$3,167,68064,0000.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders